BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1888191)

  • 41. [Liver damage in lymphoma and its clinical significance].
    Pan JX
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):224-6. PubMed ID: 7505218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Secondary non-Hodgkin lymphoma of the prostate: a case report].
    Maeda N; Nishizaki S; Furubayashi T
    Hinyokika Kiyo; 1996 Jul; 42(7):537-8. PubMed ID: 8809566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes].
    Kobayashi M; Sao H; Mizuta S; Kamiya O; Ohara K; Nagata K; Takeyama H; Watanabe E; Yamada H; Mizuno H
    Rinsho Ketsueki; 1990 Oct; 31(10):1656-63. PubMed ID: 2255056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax].
    Korman DB; Snimshchikov VA
    Vopr Onkol; 1992; 38(7):859-61. PubMed ID: 1300793
    [No Abstract]   [Full Text] [Related]  

  • 45. [Indirect endolymphatic chemotherapy of patients with lymphoma].
    Kindzel'skiĭ LP; Gubareva AA
    Vrach Delo; 1989 Jun; (6):64-6. PubMed ID: 2781767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of malignant lymphoma in Jichi Medical School Hospital. 3) Treatment of advanced bad-risk lymphoma with the M-CHOP regimen].
    Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Komatsu N; Takeda K; Muroi K; Ohsaka A; Miwa A; Yoshida M
    Rinsho Ketsueki; 1988 Jun; 29(6):833-9. PubMed ID: 3418885
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of aggressive non-Hodgkin's lymphoma.
    Coiffier B
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):12-20. PubMed ID: 10561013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Malignant lymphoma of the testis: report of two cases].
    Ito H; Fuse H; Hirano S; Masuda S; Takeshima M
    Hinyokika Kiyo; 1997 Aug; 43(8):599-603. PubMed ID: 9310787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.
    Czuczman MS
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):88-96. PubMed ID: 10561023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary non-Hodgkin's lymphoma of the vagina.
    Raspagliesi F; Ditto A; Fontanelli R; Gallino G; Massone PB; De Palo G
    Haematologica; 2000 Jun; 85(6):666-7. PubMed ID: 10870129
    [No Abstract]   [Full Text] [Related]  

  • 52. P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II study.
    Cocconi G; Franciosi V; Dodero A; Bologna A; Vasini G; De Lisi V; Di Blasio B; Ceci G; Camisa R; Cascinu S
    Am J Clin Oncol; 2003 Dec; 26(6):535-42. PubMed ID: 14663368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Modified CHOP therapy in patients with non-Hodgkin's lymphoma].
    Misago M; Chiba S; Tsukada J; Nakata K; Sato T; Nagata K; Mori N; Wake A; Ogawa R; Kikuchi M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1007-11. PubMed ID: 2029185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The results of the combined chemoradiation treatment of lymphosarcomas corresponding to the degree of its intensity].
    Kruglova GV; Finogenova IA; Shramko AF
    Ter Arkh; 1991; 63(7):105-9. PubMed ID: 1788785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Results of treatment of lymphosarcoma according to the CVP program].
    Shramko AF; Kruglova GV; Poddubnaia IV
    Ter Arkh; 1978; 50(7):80-4. PubMed ID: 581423
    [No Abstract]   [Full Text] [Related]  

  • 56. Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
    Okamoto T; Okada M; Wakae T; Mori A; Takatsuka H; Kakishita E
    Int J Hematol; 2002 Jan; 75(1):107-8. PubMed ID: 11843282
    [No Abstract]   [Full Text] [Related]  

  • 57. Malignant lymphoma of the mandible: report of a case.
    Kawasaki G; Nakai M; Mizuno A; Nakamura T; Okabe H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Mar; 83(3):345-9. PubMed ID: 9084197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paraneoplastic pemphigus associated with non-Hodgkin's lymphoma.
    Ishigami T; Kubo Y; Matsudate Y; Ansai S; Arase S; Ohyama B; Hashimoto T
    Eur J Dermatol; 2011; 21(1):122-4. PubMed ID: 21190909
    [No Abstract]   [Full Text] [Related]  

  • 59. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
    Taillan B; Garnier G; Schneider S; Pesce A; Fuzibet JG; Dujardin P
    Cancer; 1993 May; 71(9):2881-2. PubMed ID: 7682156
    [No Abstract]   [Full Text] [Related]  

  • 60. [Combination chemotherapy with vincristine, cyclophosphamide, procarbazine and prednisolone in advanced reticulum cell sarcoma (author's transl)].
    Yoshikawa S; Morishima Y
    Rinsho Ketsueki; 1976 Jul; 17(7):764-9. PubMed ID: 789933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.